Axios @axios
Doctors are urging the FDA to convene an expert panel to review safety concerns around an Alzheimer's drug that won accelerated approval in January, citing reports of "brain swelling, brain bleeding and death." https://t.co/pLsjivAvPn — PolitiTweet.org